Minimal residual disease in Philadelphia-positive acute lymphoblastic leukemia: Maximizing the clinical yield of testing

被引：1
作者：
Saliba, Antoine N. [1 ]
Foa, Robin [2 ]
机构：
[1] Mayo Clin, Div Hematol, Rochester, MN USA
[2] Sapienza Univ, Dept Translat & Precis Med, Hematol, Rome, Italy
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2023年 / 98卷 / 08期
关键词：
CONSENSUS RECOMMENDATIONS; FLOW-CYTOMETRY; CELL-RECEPTOR; RISK; MRD; RELAPSE; ADOLESCENTS; IMATINIB; THERAPY;
D O I：
10.1002/ajh.26993
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1168 / 1170
页数：3
相关论文
共 29 条
  • [1] Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL)
    Bassan, Renato
    Spinelli, Orietta
    Oldani, Elena
    Intermesoli, Tamara
    Tosi, Manuela
    Peruta, Barbara
    Rossi, Giuseppe
    Borlenghi, Erika
    Pogliani, Enrico M.
    Terruzzi, Elisabetta
    Fabris, Pietro
    Cassibba, Vincenzo
    Lambertenghi-Deliliers, Giorgio
    Cortelezzi, Agostino
    Bosi, Alberto
    Gianfaldoni, Giacomo
    Ciceri, Fabio
    Bernardi, Massimo
    Gallamini, Andrea
    Mattei, Daniele
    Di Bona, Eros
    Romani, Claudio
    Scattolin, Anna Maria
    Barbui, Tiziano
    Rambaldi, Alessandro
    [J]. BLOOD, 2009, 113 (18) : 4153 - 4162
  • [2] Association of Minimal Residual Disease With Clinical Outcome in Pediatric and Adult Acute Lymphoblastic Leukemia AMeta-analysis
    Berry, Donald A.
    Zhou, Shouhao
    Higley, Howard
    Mukundan, Lata
    Fu, Shuangshuang
    Reaman, Gregory H.
    Wood, Brent L.
    Kelloff, Gary J.
    Jessup, J. Milburn
    Radich, Jerald P.
    [J]. JAMA ONCOLOGY, 2017, 3 (07)
  • [3] Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children's Oncology Group study AALL0232
    Borowitz, Michael J.
    Wood, Brent L.
    Devidas, Meenakshi
    Loh, Mignon L.
    Raetz, Elizabeth A.
    Salzer, Wanda L.
    Nachman, James B.
    Carroll, Andrew J.
    Heerema, Nyla A.
    Gastier-Foster, Julie M.
    Willman, Cheryl L.
    Dai, Yunfeng
    Winick, Naomi J.
    Hunger, Stephen P.
    Carroll, William L.
    Larsen, Eric
    [J]. BLOOD, 2015, 126 (08) : 964 - 971
  • [4] The presence of typical and atypical BCR-ABL fusion genes in leukocytes of normal individuals: Biologic significance and implications for the assessment of minimal residual disease
    Bose, S
    Deininger, M
    Gora-Tybor, J
    Goldman, JM
    Melo, JV
    [J]. BLOOD, 1998, 92 (09) : 3362 - 3367
  • [5] Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors: A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (GITMO)
    Candoni, Anna
    Rambaldi, Alessandro
    Fanin, Renato
    Velardi, Andrea
    Arcese, William
    Ciceri, Fabio
    lazzarotto, Davide
    Lussana, Federico
    Olivieri, Jacopo
    Grillo, Giovanni
    Parma, Matteo
    Bruno, Benedetto
    Sora, Federica
    Bernasconi, Paolo
    Saccardi, Riccardo
    Foa, Robin
    Sessa, Mariarosa
    Bresciani, Paola
    Giglio, Fabio
    Picardi, Alessandra
    Busca, Alessandro
    Sica, Simona
    Perruccio, Katia
    Zucchetti, Elisa
    Diral, Elisa
    Iori, Anna Paola
    Colombo, Anna Amelia
    Tringali, Stefano
    Santarone, Stella
    Irrera, Giuseppe
    Mancini, Stefano
    Zallio, Francesco
    Malagola, Michele
    Albano, Francesco
    Carella, Angelo Michele
    Olivieri, Attilio
    Tecchio, Cristina
    Dominietto, Alida
    Vacca, Adriana
    Sorasio, Roberto
    Orciuolo, Enrico
    Risitano, Antonio Maria
    Leotta, Salvatore
    Cortelezzi, Agostino
    Mammoliti, Sonia
    Oldani, Elena
    Bonifazi, Francesca
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (12) : 2388 - 2397
  • [6] Predictive value of minimal residual disease in Philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies
    Cazzaniga, Giovanni
    De Lorenzo, Paola
    Alten, Julia
    Roettgers, Silja
    Hancock, Jeremy
    Saha, Vaskar
    Castor, Anders
    Madsen, Hans O.
    Gandemer, Virginie
    Cave, Helene
    Leoni, Veronica
    Koehler, Rolf
    Ferrari, Giulia M.
    Bleckmann, Kirsten
    Pieters, Rob
    van der Velden, Vincent
    Stary, Jan
    Zuna, Jan
    Escherich, Gabriele
    zur Stadt, Udo
    Arico, Maurizio
    Conter, Valentino
    Schrappe, Martin
    Valsecchi, Maria Grazia
    Biondi, Andrea
    [J]. HAEMATOLOGICA, 2018, 103 (01) : 107 - 115
  • [7] Chiaretti S, 2022, HemaSphere, V6, P253
  • [8] Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study
    Conter, Valentino
    Bartram, Claus R.
    Valsecchi, Maria Grazia
    Schrauder, Andre
    Panzer-Gruemayer, Renate
    Moericke, Anja
    Arico, Maurizio
    Zimmermann, Martin
    Mann, Georg
    De Rossi, Giulio
    Stanulla, Martin
    Locatelli, Franco
    Basso, Giuseppe
    Niggli, Felix
    Barisone, Elena
    Henze, Guenter
    Ludwig, Wolf-Dieter
    Haas, Oskar A.
    Cazzaniga, Giovanni
    Koehler, Rolf
    Silvestri, Daniela
    Bradtke, Jutta
    Parasole, Rosanna
    Beier, Rita
    van Dongen, Jacques J. M.
    Biondi, Andrea
    Schrappe, Martin
    [J]. BLOOD, 2010, 115 (16) : 3206 - 3214
  • [9] Optimizing Molecular Minimal Residual Disease Analysis in Adult Acute Lymphoblastic Leukemia
    Della Starza, Irene
    De Novi, Lucia Anna
    Elia, Loredana
    Bellomarino, Vittorio
    Beldinanzi, Marco
    Soscia, Roberta
    Cardinali, Deborah
    Chiaretti, Sabina
    Guarini, Anna
    Foa, Robin
    [J]. CANCERS, 2023, 15 (02)
  • [10] Droplet Digital PCR Improves IG-/TR-based MRD Risk Definition in Childhood B-cell Precursor Acute Lymphoblastic Leukemia
    Della Starza, Irene
    Nunes, Vittorio
    Lovisa, Federica
    Silvestri, Daniela
    Cavalli, Marzia
    Garofalo, Andrea
    Campeggio, Mimma
    De Novi, Lucia Anna
    Soscia, Roberta
    Oggioni, Carlotta
    Mussolin, Lara
    Biondi, Andrea
    Guarini, Anna
    Valsecchi, Maria Grazia
    Conter, Valentino
    Biffi, Alessandra
    Basso, Giuseppe
    Foa, Robin
    Cazzaniga, Giovanni
    [J]. HEMASPHERE, 2021, 5 (03):
123